Financially independent since age 13 (1997), Wharton graduate (2009), lived and worked in the US, China and Singapore, plus extensive operating and investment experience in Europe. Transformed Esco into a global life science and medical equipment manufacturer and solutions provider, growing shareholder value 25% CAGR over more than 15 years (since 2000). Developed multiple products and technologies from concept to profitable commercial reality, multiple patents and cumulative revenues over 1B dollars. Esco products are sold today in more than 100 countries, with more than 130,000 systems installed. Created hundreds of millions in shareholder value and an enduring Lim (Lin) family owned business platform with operations across the US, Europe and Asia, with 1000 employees. Founded Esco Ventures in 2014, portfolio IRR ~45% to date. Flagship medtech portfolio company, AT Medical / Esco Medical, a global leader in fertility technologies, impacting more than 100,000 live births annually. Co Founded Carmentix (currently clinical stage) in 2015, developing first in class prognostic tools to dramatically improve pregnancy and neonatal outcomes globally, and save billions of dollars annually for the US healthcare system. Launched Esco Ventures X in 2018, Asia’s factory for biotech start-ups. Currently launching a rare disease biotech start-up (in stealth mode). Synergistic business partner to entrepreneurial scientists/innovators — bringing early stage capital, strong instincts, a nose for good science, global business acumen/networks/resources, and track record in taking technologies from concept to commercial reality.